Selected article for: "clinical diagnosis and diagnosis confirm"

Author: Ingrid Arevalo-Rodriguez; Diana Buitrago-Garcia; Daniel Simancas-Racines; Paula Zambrano-Achig; Rosa del Campo; Agustin Ciapponi; Omar Sued; Laura Martinez-Garcia; Anne Rutjes; Nicola Low; Jose A Perez-Molina; Javier Zamora
Title: FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEW
  • Document date: 2020_4_21
  • ID: g8h6trql_8
    Snippet: Because the signs of infection mentioned above are non-specific, confirmation of cases is currently 81 based on the detection of a viral sequence by reverse transcription-polymerase chain reaction . Different RT-PCR schemes have been proposed; all of them include the N gene that codes for 83 the viral nucleocapsid. Other alternative targets are the E gene, for the viral envelope, or the S gene 84 for the spike, and the Hel gene for the RNA polyme.....
    Document: Because the signs of infection mentioned above are non-specific, confirmation of cases is currently 81 based on the detection of a viral sequence by reverse transcription-polymerase chain reaction . Different RT-PCR schemes have been proposed; all of them include the N gene that codes for 83 the viral nucleocapsid. Other alternative targets are the E gene, for the viral envelope, or the S gene 84 for the spike, and the Hel gene for the RNA polymerase gene (RdRp/Helicase) [12, 13] . Molecular 85 criteria for in vitro diagnosis of COVID-19 disease are heterogeneous, and usually require the 86 detection of two or more genes of SARS-CoV-2 [14] . 87 RT-PCR repeated testing might be required to confirm a clinical diagnosis, especially in the presence 88 of symptoms close related to COVID-19 disease [15] . Cases with negative RT-PCR results at initial 89 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • alternative target and clinical diagnosis: 1
    • alternative target and reverse transcription polymerase chain reaction: 1
    • case confirmation and cc NC ND International license: 1, 2, 3, 4, 5, 6, 7, 8
    • case confirmation and chain reaction: 1, 2, 3, 4, 5, 6, 7, 8
    • case confirmation and clinical diagnosis: 1, 2, 3, 4, 5, 6
    • case confirmation and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • case confirmation and polymerase gene: 1
    • case confirmation and reverse transcription polymerase chain reaction: 1, 2
    • cc NC ND International license and chain reaction: 1, 2, 3, 4
    • cc NC ND International license and clinical diagnosis: 1, 2, 3, 4, 5
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and polymerase gene: 1, 2, 3, 4
    • cc NC ND International license and reverse transcription polymerase chain reaction: 1, 2
    • chain reaction and clinical diagnosis confirm: 1, 2, 3, 4
    • chain reaction and International license: 1, 2, 3, 4, 5
    • chain reaction and polymerase gene: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and repeat testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and reverse transcription polymerase chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and RT PCR repeat testing: 1, 2, 3, 4, 5, 6